Novel insights into immune and inflammatory responses to respiratory viruses

Research output: Contribution to journalReview articlepeer-review

Abstract / Description of output

Viral lower respiratory tract infection (LRTI) can lead to severe disease at all ages, but with the exception of influenza vaccination, prevention is not available for most respiratory viruses, hence, effective, disease-limiting therapy is urgently required. To enable the development of novel effective therapeutic approaches, we need to improve understanding of the pathological mechanisms of viral LRTI. Here, we will discuss recently gained new insight into early, innate immune and inflammatory responses to respiratory viruses by airway epithelial cells and mucosal immune cells. Following virus recognition, these cells generate a range of mediators, including innate interferons, proinflammatory cytokines, and growth and differentiation factors which have pivotal roles in effective virus control, and the development of inflammation and disease in viral LRTI.

Original languageEnglish
Pages (from-to)108-110
Number of pages3
JournalThorax
Volume68
Issue number1
DOIs
Publication statusPublished - Jan 2013

Fingerprint

Dive into the research topics of 'Novel insights into immune and inflammatory responses to respiratory viruses'. Together they form a unique fingerprint.

Cite this